CMS’ Proposed Rule on 'Breakthrough' Medical Devices Builds on a Flawed System
Provider Payment Incentives
CMS’ Proposed Rule on ‘Breakthrough’ Medical Devices Builds on a Flawed System
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Drug Prices
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
Drug Prices
‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers
Surprise Medical Billing Remains a Threat to Patients Amid Health, Economic Crisis
Commercial Sector Prices
Surprise Medical Billing Remains a Threat to Patients Amid Health, Economic Crisis
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
Commercial Sector Prices
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Texas Hospitals Sue Patients Over Medical Debt
Commercial Sector Prices
Texas Hospitals Sue Patients Over Medical Debt
Debunking Myths in the Surprise Billing Debate
Commercial Sector Prices
Debunking Myths in the Surprise Billing Debate
Medicare-Medicaid Integration
A Letter to the CMS on Medicare Advantage Plan Rules
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Drug Prices
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
The Surprising Force Behind Surprise Medical Bills
Commercial Sector Prices
The Surprising Force Behind Surprise Medical Bills
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Health
- Public Finance
- Higher Education & Career Pathways
- Infrastructure
- Evidence & Evaluation
